CD4
+ regulatory T cells (Tregs) are essential for controlling immune responses and preventing autoimmunity. Their development requires regulation of gene expression by microRNAs (miRNAs). To understand miRNA function in Treg development, we searched for important miRNAs and their relevant target genes. Of the more abundantly expressed miRNAs in Tregs, only miR-15b/16, miR-24, and miR-29a impacted the production of in vitro-induced Tregs (iTregs) in overexpression and blocking experiments. miRNA mimics for these significantly enhanced the induction of iTregs in Dicer 2/2 CD4 + T cells. Furthermore, the overexpression of miR-15b/16 in conventional CD4 + T cells adoptively transferred into Rag2 2/2 mice increased the in vivo development of peripheral Tregs and diminished the severity of autoimmune colitis. In searching for targets of miR-15b/16, we observed that the mammalian target of rapamycin (mTOR) signaling pathway was enhanced in Dicer 2/2 CD4 + T cells, and its pharmacological inhibition restored induction of iTregs. Suppression of mTOR signaling is essential for induction of iTregs from naive CD4 + T cells, and the mTORC2 component, Rictor, contained a functional target site for miR-15b/16. Rictor was more abundantly expressed in Dicer 2/2 T cells as was mTOR, and their expression was downregulated by the overexpression of miR15b/16. This led to a reduction in mTOR signaling, as measured by phosphorylation of the downstream target, ribosomal protein S6. Finally, knockdown of Rictor by small interfering RNAs enhanced Treg induction in Dicer 2/2 CD4 + T cells. Therefore, an important mechanism of miRNA regulation of Treg development is through regulation of the mTOR signaling pathway. The Journal of Immunology, 2015, 195: 000-000.
R egulation of the immune response and the prevention of autoimmunity require a class of Th cells called regulatory T cells (Tregs).
Because of their essential function in maintaining peripheral tolerance, they play important roles in many immune-related disorders. Therefore, a significant interest exists in understanding their development and function to develop new therapeutic strategies for diseases involving the immune response (1) .
The majority of circulating Tregs are produced in the thymus at the double-positive stage and are designated thymus-derived Tregs (tTregs). Current thought is that they enter the Treg lineage because of an intermediate affinity of their TCR to self-antigens, which is above that normally required for positive selection but not sufficient for negative selection. This is hypothesized to induce a suppressor phenotype that protects the body against any subsequent immune response that might develop against self-antigens (1). Tregs can also develop in the periphery from naive T CD4 + T cells when activated under the influence of specific factors (e.g., TGF-b and retinoic acid) produced by APCs and other cell types present at the site of Ag challenge. These are designated peripherally-derived Tregs (pTregs). Both tTregs and pTregs are important in preventing autoimmune disease (2, 3) . Each is defined by the expression of the Treg-specific transcription factor Foxp3, which plays an essential role in regulating the gene expression profile required for Treg development and function. Loss of Foxp3 results in the absence of Tregs and subsequent lethal autoimmunity (4) .
MicroRNAs (miRNAs) are critical regulators of Treg development and function. These are small double-stranded RNAs ∼22 nt in length that negatively regulate gene expression at a posttranscriptional stage (5) . miRNAs are encoded in the genome within pol II transcripts. Their critical feature is a stem loop structure made up of the complementary strands of the miRNA, which is recognized and cleaved by protein complexes containing the RNases Drosha and Dicer to give the mature miRNA. This is incorporated into an effector complex called the RNA-induced silencing complex. One strand is degraded, and the other can target the complex to messages through imperfect base pairing, which typically occurs in the 39-untranslated region (UTR) of the gene. This results in inhibition of translation and the subsequent destabilization of the message (6) . The loss of miRNAs at the double-positive stage of T cell development through a conditional knockout of Drosha or Dicer significantly inhibits the development of Tregs and ultimately leads to autoimmunity (7, 8) . In addition, a deletion of either RNase specifically in Tregs disrupts their suppressor function and results in an acute autoimmune response that is as severe as the loss of Foxp3 (8) (9) (10) . Therefore, miRNAs are important in the steps leading up to commitment toward the Treg lineage and also downstream in mediating their suppressor function. Several studies examined the roles of miRNAs in Treg function and identified individual miRNAs that regulate key genes required for the function and stability of Tregs (11) (12) (13) (14) (15) (16) (17) . However, it is still unknown how miRNAs regulate the expression of genes involved in the developmental steps leading to the Treg lineage.
We set about to examine miRNA function in Treg development by first determining functional miRNAs and then identifying critical genes that they regulate. We found three miRNAs (miR15b/16, miR-24, and miR-29a) that regulated the induction of Tregs from naive CD4 + T cells, with miR-15b/16 having the greatest effect in overexpression and blocking experiments. Important genes regulated by miR-15b/16 were Rictor and Mtor, which encode components of the mammalian target of rapamycin (mTOR) signaling pathway. Downregulation of the mTOR signaling pathway is important for the induction of Tregs (18) (19) (20) . Therefore, miR-15b/16 plays an important role in regulating the mTOR signaling pathway and controlling the development of Tregs.
Materials and Methods
Mouse strains, Abs, and plasmids C57BL/6 (Charles River, Harlow, U.K.), Rag2 2/2 (kindly donated by Dr. Jian-Guo Chai, Imperial College London, London, U.K.), and CD4-Cre Dicer lox/lox (7) mice were used for the experiments and kept in a conventional specific pathogen-free facility. All animal work was performed according to the Animals (Scientific Procedures) Act 1996, UK under animal Project License 70/6965.
Abs for flow cytometry experiments were all directed against mouse Ags. They included CD4-FITC/PE/PerCP/allophycocyanin (clone GK1.5), CD8a-PerCP (clone 53-6.7), CD25-PE (clone PC61.5), Foxp3-allophycocyanin (clone FJK-16s), IFN-g-FITC or IFN-g-eFluor 450 (clone XMG1.2), IL-17-PE (all from eBioscience), and IL-17a-PE (clone TC11-18H10) (BD Biosciences). Western blot Abs (all rabbit mAbs) were p-SMAD2 (S465/467), total SMAD2/3, phosphatase and tensin homolog (PTEN; clone D4.3) XP, PDK-1, p-PDK-1 (S241), p-AKT (S473) (clone D9E) XP, p-AKT (T308) (clone C31E5E), total AKT (pan) (clone C67E7), mTOR (clone 7C10), Rictor (clone 53A2), p-FoxO1 (S256), total FoxO1a (clone C29H4), p-FoxO3a (S253), total FoxO3a (clone 75D8), p-S6 ribosomal protein (Ser 235/236 ) (clone D57.2.2E) XP, GAPDH (clone D16H11) XP, and b-actin (clone 8H10D10) (all from Cell Signaling).
miRNA expression vectors were derived by cloning the genomic region encoding specific miRNAs into the retroviral pMIG vector. Expression of miRNAs was confirmed by miRNA-quantitative real time RT-PCR (qRT-PCR). miRNA decoy or sponge transcripts were designed as described (21, 22) . Decoy sequences were cloned into the pSIF lentiviral vector for PolIII expression. Sponge sequences were cloned into pMIG. miRNA reporter constructs contained the 39UTR of Rictor inserted downstream of luciferase in pGL3. Details about the vectors are available upon request.
Isolation of naive T cells and activation into Th subsets
Naive CD4 + CD62L high CD25 2 T cells were isolated from spleen and lymph nodes (inguinal, axillary, brachial, mediastinal, superficial cervical, mesenteric) of 6-8-wk-old female C57BL/6 mice using magnetic beads for CD4 + selection (Dynabeads Untouched Mouse CD4 Cells Kit; Invitrogen), followed by CD25 and CD62L selection using biotinylated anti-CD25 (7D4 clone) or biotinylated anti-CD62L (clone MEL-14; both from BD Biosciences) and Streptavidin MicroBeads with MACS separation columns (Miltenyi Biotec).
Naive CD4 + CD62L high CD25 2 T cells were cultured in complete medium (RPMI 1640, penicillin/streptomycin, L-glutamine, HEPES, and 2-ME; all from Sigma) and 10% FBS. They were activated in the presence of plate-bound anti-CD3/anti-CD28 Abs (eBioscience) at a 1:2 ratio (1 mg/ml anti-CD3/2 mg/ml anti-CD28) for Th1, Th2, and in vitroinduced Tregs (iTregs) and a 1:10 ratio (1 mg/ml anti-CD3/10 mg/ml anti-CD28) for Th17. Activated T cells were differentiated into Th1 using 20 ng/ml rIL-12 (eBioscience) and anti-IL-4 (5 mg/ml; BD Biosciences); into Th2 using 20 ng/ml rIL-4 (BD Biosciences) and anti-IFN-g (5 mg/ml; BD Biosciences); into Th17 using 2.5 ng/ml rTGF-b, 50 ng/ml rIL-6 (eBioscience), anti-IFN-g (5 mg/ml), anti-IL-4 (5 mg/ml), and anti-IL-2 (5 mg/ml; BD Biosciences); and into iTregs using 2.5 ng/ml rTGF-b and 5 ng/ml rIL-2 (eBioscience). Analysis was performed on cells after 3-4 d of culture.
Retroviral transduction and transfection of miRNA mimics and small interfering RNAs into T cells
Retroviruses were produced by calcium phosphate transfection of HEK 293T cells with the retroviral expression and the pcL-Eco helper virus vectors. Culture supernatants were harvested and used to spin-infect naive CD4 + T cells that were activated overnight by plate-bound anti-CD3/anti-CD28 Abs. Cells were differentiated into iTregs as described above. To compare the effects of different miRNAs, an average Z score was calculated from individual experiments, as described (23): Z = (x -y)/SD. In this calculation, x = iTreg index, which is the percentage of Foxp3 + cells induced in the control or with the expression of an individual miRNA; y = the mean of all the iTreg indices in a given experiment; and SD = the SD of all these iTreg indices.
miRNA mimics or small interfering RNAs (siRNAs) were transfected into naive CD4 + T cells using DharmaFECT 3 miRNA mimic transfection reagent or siRNA Accell delivery medium, respectively, per the manufacturer's guidelines (Dharmacon). For the miRNA mimic transfections, the negative control oligonucleotide, consisting of a random sequence, contained a DY547 fluorescent tag for determining transfection efficiency, which was ∼50% in each experiment.
Immunoassays
Immunostaining for flow cytometric analysis was performed using the respective Abs. For intracellular staining of cytokines, cells were treated with 1 mg/ml PMA, 1 mg/ml ionomycin, and 1 mg/ml brefeldin A for 2 h prior to staining. For Foxp3 staining, cells were fixed with Foxp3 Fixation/Permeabilization Buffer (eBioscience) for 30 min prior to staining; if GFP was also detected, cells were fixed with 2% paraformaldehyde for 5 min prior to fixation/permeabilization. Data were acquired using a FACSCanto II (BD) and analyzed using FlowJo software (TreeStar).
Cytokine in culture supernatants from differentiated T cells was detected using the FlowCytomix multiple analysis detection kit for Th1/Th2 cytokines (eBioscience).
Western blot analysis was performed from total cell extracts prepared from naive CD4 + T cells that were either left unactivated or activated for 30 min with plate-bound anti-CD3/anti-CD28 (1:2), with or without the addition of 2.5 ng/ml TGF-b. Proteins were detected using the indicated Abs and a HRP-conjugated secondary Ab and then visualized using the ECL detection system. Quantitation was performed by densitometric analysis of exposed films.
miRNA and mRNA qRT-PCR RNA was isolated from CD4 + T cells using miRNeasy (for miRNAs) or mRNeasy (for mRNAs) isolation kits (QIAGEN). For miRNA detection, cDNA synthesis and subsequent quantitative real-time PCR (qPCR) with locked nucleic acid primers for specific miRNAs was performed using miRCURY LNA Universal RT microRNA cDNA synthesis and qPCR kit (EXIQON). For mRNA detection, cDNA was prepared using the miScript cDNA synthesis kit (QIAGEN). qPCR was performed using IQ Bio-Rad SYBR Green Master Mix (Bio-Rad) with the following primers for Rictor (forward: 59-ACCGGGCTTCTGACCATTAAA-39 and reverse: 59-TTGT-ATGAACCGCCGACACT-39). Measurements were performed using Chromo 4 Bio-Rad PCR machines. The relative expression level of miRNAs was normalized to that of 5S rRNA and U6 small nuclear RNA, whereas the relative expression level of mRNAs was normalized to that of b-actin, as described previously (24) .
Adoptive T cell-transfer colitis model C57BL/6 Rag2 2/2 mice were injected into the peritoneal cavity with 10 6 GFP FACS-sorted naive CD4 + CD62L high CD25 2 T cells that were transduced with either control or miR-15b/16-expressing retroviruses. Weight was monitored every week, and mice were sacrificed after 8 wk (or when weight was reduced by 20%) for analysis. Histopathological review was performed as previously described (12, 25) . The large intestine (from the ileocecocolic junction to anorectal junction) was removed and processed. Sections were stained with H&E, coded, and assigned a score in a blinded fashion. The severity of colitis was graded semiquantitatively on an overall scale of 0 to 5, assessing the degree of epithelial hyperplasia and goblet cell depletion, leukocyte infiltration in the lamina propria, area of tissue affected, and the presence of markers of severe inflammation, such as crypt abscesses, submucosal inflammation, and ulcers. The total colonic score was calculated as the median of the individual scores of sections of proximal colon, midcolon, and distal colon.
39UTR luciferase reporter assay
The 39UTR of Rictor was cloned downstream of the firefly luciferase gene in the pGL-3 vector. HEK 293 T cells were transfected with this vector (or the mutated miR-15/16 target site vector), internal control pRL Renilla luciferase vector, and the miRNA overexpression vector. After 48 h, luciferase activity was measured using the Dual-Luciferase reporter assay system (Promega). Luciferase activity was measured with a Wallac 1420 VICTOR2 multilabel plate reader (Perkin Elmer).
Statistical analysis
Statistical analyses, using the Student t test, were performed with Prism software (GraphPad). Figures were created using Excel and GraphPad Prism software. The p values #0.05 were considered significant.
Results

Identification of important miRNAs
To analyze miRNA function in Treg development, a model system was needed in which individual miRNAs could be manipulated and tested. Therefore, we used an in vitro model of Treg induction involving the activation of naive CD4 + T cells in the presence of TGF-b plus IL-2 and measured the differentiation into the Treg lineage by the expression of Foxp3. This model represents the development of pTregs, which, along with tTregs, are critical in suppressing the immune response and preventing autoimmune disease (2, 3) . Furthermore, the induction of iTregs is significantly reduced in Dicer 2/2 CD4 + T cells just like the in vivo development of Tregs in the mutant mice (7) . For this model, we hypothesized that important miRNAs would be abundant and more highly expressed in iTregs compared with conventionally activated CD4 + T cells or those polarized to other Th subsets. Our previous miRNA-profiling experiments (7) identified multiple miRNAs that are more highly expressed in ex vivo-derived Tregs compared with activated conventional CD4 + T cells. These miRNAs were felt to be the most likely candidates to be involved in the induction of iTregs, so their relative level was determined by qPCR in iTregs and compared with other Th subsets. These included resting naive CD4 + T cells and those activated under nonpolarizing or polarizing conditions toward Th1, Th2, or Th17 subsets. miRNAs that were more abundantly expressed in ex vivo Tregs (miR-15b, 16, 21, 24, 29a, 92b, 142 59, 142 39 146a, 150, and 223) were also the most abundant in iTregs compared with T cells cultured in other conditions; conversely, those that were not abundantly expressed in ex vivo Tregs (miR-23a, 30c, 99b, 125a, 191, and 326) were not abundantly expressed in iTregs (Fig. 1A) . Therefore, we focused on the function of the miRNAs that were most abundantly expressed in iTregs.
The function of individual miRNAs was examined by measuring the effect of their overexpression or blocking in iTreg induction. Overexpression was achieved through the use of retroviruses that expressed genomic sequences encoding the miRNAs. Blocking was achieved through the use of lentiviruses or retroviruses that expressed miRNA decoy or "sponge" target sequences, respectively. These viruses were transduced into CD4 + T cells, and iTregs were induced by the addition of TGF-b plus IL-2. Because the viruses also encoded GFP to track their expression, GFP + cells were analyzed for the induction of iTregs by the expression of Foxp3. The miRNAs that had the greatest effect in these experiments were miR-15b and miR-16, which are encoded within the same primary transcript and are closely related, such that they target the same sequences in mRNAs. Overexpression of miR15b/16 significantly increased the induction of iTregs compared with cells transduced with a control retrovirus lacking any miRNA sequences (Fig. 1B) . Likewise, expression of decoys for either miR-15b or miR-16 inhibited the induction of iTregs (Fig. 1C) .
These effects were dependent on the level of expression of the miRNAs or decoys, as deduced from GFP expression. Cell populations within gates of increasing GFP expression were more affected in iTreg induction (Fig. 1D) .
Comparing the effects of all of the miRNAs tested using a Z-score analysis (as described in Materials and Methods) revealed that miR-24 and miR-29a were the only other miRNAs to have a significant positive effect on the induction of iTregs (Fig. 1E) . All of these positive-acting miRNAs could also partially reverse the defect in iTreg induction in Dicer 2/2 CD4 + T cells. Transfection of miRNA mimics for miR-15b, miR-24, or miR-29a enhanced the induction of iTregs in Dicer 2/2 CD4 + T cells, whereas miR-21 (which did not have an effect in overexpression and blocking experiments) failed to do so. In addition, transfection of a combination of miR-15b, miR-16, and miR-29a into Dicer 2/2 CD4 + T cells brought the level of iTreg induction nearly back to that seen in Dicer +/2 CD4 + T cells (Fig. 1F) . Therefore, these miRNAs appear to be most important in regulating the induction of iTregs. It is interesting to note that, in contrast to the importance of miR15b/16 in the overexpression and blocking studies, miR-29a was most effective in the complementation studies. However, the biological significance of this observation remained unclear. The difference could have been due to the different experimental systems or to differences in expression of the miRNAs between transfection and retroviral transduction.
To test whether overexpression of miR-15b/16 could also enhance the development of pTregs in vivo, Rag2 2/2 mice were reconstituted with conventional Th cells (CD4 + CD25
2 ) transduced with control or miR-15b/16-expressing retroviruses. The autoimmune reaction observed with this reconstitution was significantly inhibited by the overexpression of miR-15b/16, as measured by weight loss and histopathological review of the colon ( Fig. 2A-C) . In addition, the total numbers of mononuclear cells populating the spleen were significantly reduced when miR-15b/16 was overexpressed, as was the number of CD4 + T cells (Fig. 2D) . Consistent with the reduction in the total number of T cells, there were fewer IFN-g-producing cells in the spleen when miR-15b/16 was overexpressed. Likewise, there appeared to be fewer IL-17-producing cells, but this difference did not reach statistical significance. Interestingly, the percentages of IFN-g and IL-17-producing cells were not statistically different, so the overexpression of miR-15b/16 did not appear to specifically impact the development of Th1 and Th17 cells over other Th subsets. Therefore, the reduction in the inflammatory response was most likely due to the overall reduction in T cell numbers. This could have been due to multiple effects of miR-15b/16 overexpression, but most importantly, there was a significant increase in the percentage of pTregs at the sites of inflammation (spleen, lungs, and mesenteric lymph nodes) but not away from the site of inflammation within peripheral lymph nodes (Fig. 2F) . Therefore, similar to the in vitro experiments, the overexpression of miR-15b/16 in CD4 + T cells enhanced the peripheral development of Tregs, and this was consistent with the reduced numbers of T cells and the attenuation of the autoimmune response. Alternative explanations for the decrease in autoimmunity might include suppression of T cell proliferation or activation of cell death because miR-15/16 can inhibit cell growth (26) and induce apoptosis (27) . However, overexpression of miR15b/16 did not affect T cell proliferation or apparent viability in vitro (Supplemental Fig. 1A ), so it is uncertain whether these issues were important in vivo. Additionally, miR-15b/16 could have impacted the suppressive function of Tregs, but our attempts to examine the suppressive function of Tregs was hampered by the fact that ex vivo-isolated Tregs transduced to overexpress miR-15b/16
The Journal of Immunologymaintained Foxp3 expression much more stably when cultured in vitro (Supplemental Fig. 1B) . Therefore, any effects on suppressive function would be difficult to interpret. Finally, to determine whether the effect of miR-15b/16 on pTreg development was cell intrinsic or due to extrinsic factors created in the immune environment where T cells overexpressed miR-15b/16, unsorted miR15b/16-transduced cells were adoptively transferred into Rag2 2/2 mice, and the percentage of pTregs was determined in both the GFP + and GFP 2 populations of CD4 + T cells. Cells overexpressing miR-15b/16 had significantly more pTregs in mesenteric lymph nodes and spleen (Supplemental Fig. 2) , suggesting that the effect of miR-15b/16 was intrinsic to the T cells overexpressing these miRNAs.
Identification of relevant genes targeted by miR-15b/16
Because miR-15b/16 had the greatest effect on iTreg induction in overexpression and blocking studies, we focused on finding relevant target genes for this miRNA family. As a first step, target prediction algorithms (28, 29) identified nearly a thousand genes with potential target sites for miR-15b/16. To narrow down this list, we decided to examine signal transduction pathways known to be important for Treg development and determine whether any were altered in Dicer of the TCR and CD28 (32) . Therefore, the importance of miRNAs in iTreg induction could be through their inhibition of IFN-g expression. Previous studies indicated that miR-29 regulates the expression of IFN-g through its regulation of the transcription factors T-bet and Eomes, which activate the expression of IFN-g (23, 33, 34) . The gene encoding T-bet (Tbx21) contains a predicted target site for miR-15b/16 in its 39UTR, in addition to the site targeted by miR-29 (29, 35) . Therefore, the importance of these miRNAs in iTreg induction could be through their targeting of Tbx21, thereby regulating IFN-g expression. To test the importance of miRNAs in the regulation of IFN-g expression, IFN-g production was determined in Dicer +/2 and Dicer 2/2 CD4 + T cells that were activated under different Th-polarizing conditions. Production of IFN-g was significantly higher in Dicer 2/2 CD4 + T cells polarized toward Th0, Th1, Th2, and Th17 subtypes, but it was virtually absent in iTregs from Dicer +/2 or Dicer 2/2 CD4 + T cells (Fig. 3A) (note: the production of IFN-g in Th2 conditions in Dicer +/2 cells was due to the lack of the addition of neutralizing Ab for IFN-g, which is required for full polarization to the Th2 subset but would prevent the measurement of IFN-g in the culture supernatants). Therefore, IFN-g production does not appear to be responsible for the reduction in the induction of iTregs in Dicer 2/2 CD4 + T cells. Furthermore, the addition of a neutralizing Ab to the low amount of IFN-g used in these studies did not significantly enhance the induction of iTregs in Dicer +/2 or Dicer 2/2 CD4 + T cells (Fig. 3B ) (in fact, induction was slightly inhibited in Dicer 2/2 CD4 + T cells). In contrast, the addition of IFN-g inhibited iTreg induction in Dicer +/2 and Dicer 2/2 CD4 + T cells. Therefore, miRNA regulation of IFN-g expression does not appear to be important for iTreg induction. Proximal TGF-b signaling events are not regulated by miRNAs. Because TGF-b signaling during T cell activation results in iTreg induction (36) , miRNAs could potentially regulate the expression of key repressors of this pathway and provide a means to fine-tune its signaling. Therefore, miRNA regulation of proximal events in this pathway were analyzed by examining the phosphorylation of the downstream transcription factor, SMAD2, which is activated through the TGF-bR complex by phosphorylation on serines 465 and 467. As shown in Fig. 4 , Dicer +/2 and Dicer 2/2 CD4 + T cells had no difference in phosphorylation of SMAD2 when activated by anti-CD3/CD28 and the addition of TGF-b. Therefore, miRNAs The development of pTregs was significantly increased. Representative experiment from spleen (left panels) and bar graphs (mean + SD) showing significant differences in the percentages of Tregs in the spleen (***p = 0.0001), lungs (**p = 0.007), and mesenteric lymph nodes (mLNs; **p = 0.002) but not away from the site of inflammation at the peripheral lymph nodes (pLNs) (right panels). Data were derived from six control and five miR-15b/16 mice. Two independent experiments were performed with similar results.
are not important for regulating TGF-b signaling up to the point of SMAD2 phosphorylation. However, it is possible that miRNAs regulate TGF-b signaling downstream of this point. Target prediction algorithms found target sites of miR-15b/16 in SMAD7, SMURF1/2, and WWP1, which are negative regulators of TGF-b signaling, but little is known about the importance of these factors in TGF-b signaling leading to iTreg induction, so their analysis was not pursued further. The mTOR signaling pathway is regulated by miRNAs. Induction of iTregs requires suppression of signaling through the mTOR pathway (18) (19) (20) . A highly simplified diagram of the pathway is shown in Fig. 5A . Briefly, stimulation of the TCR and coreceptors leads to the activation of PI3K. These phosphorylate inositol lipids at the cell membrane (countered PTEN), which then attract and activate PDK1. PDK1 phosphorylates protein kinase B/AKT (at threonine 308), leading to its activation, which ultimately results in the activation of the mTOR complex (mTORC). mTORC regulates multiple facets of cell metabolism and ultimately controls many steps in the determination of developmental fates (37) . One key mediator is ribosomal protein S6 kinase, which is activated through its phosphorylation by mTOR and then phosphorylates many cellular proteins involved in cell growth, one being ribosomal protein S6. mTORC contains the mTOR kinase and other associated proteins. Two main complexes exist that differ primarily by the inclusion of Raptor (mTORC1) or Rictor (mTORC2). mTORC1 lies downstream and is activated via events mediated by AKT. However, mTORC2 is required for full activation of AKT through its phosphorylation of serine 473. In addition to activating mTORC1, AKT phosphorylates FoxO1a and FoxO3a proteins, which are important transcription factors required for the expression of Foxp3 and the development of Tregs (38, 39) . Phosphorylation of FoxO proteins by AKT leads to their exclusion from the nucleus and subsequent degradation, which is one important mechanism through which mTOR signaling inhibits Treg development (40) .
Pharmacological inhibitors of this pathway enhance the induction of iTregs. These include LY294002, rapamycin, and AKT1/2, which inhibit PI3K, mTORC1, and AKT, respectively (20) . To determine whether miRNAs are important for suppressing the mTOR signaling pathway, the above inhibitors were tested for their effect on iTreg induction in Dicer 2/2 CD4 + T cells. As shown in Fig. 5B and 5C , LY294002 enhanced the induction of iTregs in Dicer +/2 CD4 + T cells, but it had no significant effect on Dicer 2/2 CD4 + T cells. In contrast, both rapamycin and iAKT1/2 significantly increased the induction of iTregs in Dicer +/2 and Dicer 2/2 CD4 + T cells. Therefore, miRNAs appear to be important for regulating the mTOR signaling pathway downstream of PI3K. Examining the levels of key proteins in this pathway (Fig. 5D-F) , PTEN appeared to be slightly upregulated in Dicer 
CD4
+ T cells; however, upon further experiments, this difference was not apparent and revealed no statistically significant changes. Looking downstream, the level of PDK displayed a slight increase (10%) in Dicer 2/2 CD4 + T cells that was consistent in further experiments, yielding statistically significant results. In contrast, the level of AKT was not affected by miRNAs. However, its phosphorylation at Thr 308 and Ser 473 was significantly enhanced in Dicer 2/2 CD4 + T cells, indicating an upregulation of AKT activity. This correlated with an increase in the levels of mTOR and Rictor, which are part of mTORC2 that activates AKT through phosphorylation of Ser
473
. Consistent with an increase in AKT activity was the downstream activation of mTORC1, as measured by phosphorylation of ribosomal protein S6. Likewise, the level of FoxO1a was significantly downregulated in Dicer 2/2 CD4 + T cells, and its relative phosphorylation was greatly enhanced. Because FoxO proteins are important regulators of Treg development through their activation of Foxp3 transcription (38, 39), we examined whether overexpression of FoxO3a could enhance iTreg induction in Dicer 2/2 CD4 + T cells. Induction was enhanced by FoxO3a overexpression, and this was further enhanced by overexpression of a phosphorylation mutant of FoxO3a (A3A) that contains alanine residues at the three sites phosphorylated by AKT, thus making it resistant to degradation by AKT phosphorylation (Supplemental Fig. 3) (41) . A similar increase in induction was observed with overexpression of these FoxO3a proteins in Dicer +/2 CD4 + T cells. However, the level of iTreg induction did not correlate with the absolute level of FoxO3a expression. Therefore, FoxO3a protein expression cannot, by itself, explain the effects on iTreg induction in Dicer 2/2 CD4 + T cells, and its relative importance is unclear. Rictor and mTOR are relevant targets of miR-15b/16 in iTreg induction. Target prediction algorithms identified potential target sites of miR-15b/16 in the 39UTRs of several components of the mTOR signaling pathway (29, 35) . These included Akt3, Sgk1, and Rictor. Of these, Akt3 expression was greater in Dicer 2/2
CD4
+ T cells, as measured by RNA (Y. Singh and B. Cobb, unpublished observations), but this was not thought to be relevant because, as shown above, there was no increase in the total amount of AKT in Dicer 2/2 CD4 + T cells in which the AKT Ab used for the Western blot recognizes all three isoforms (AKT1, AKT2, and AKT3). Therefore, any changes in the level of AKT3 did not affect the overall level of AKT. Sgk1 encodes serum glucocorticoid kinase (SGK)1, which is related to AKT and can phosphorylate FoxO proteins at the same sites as AKT and similarly regulate their activity (42) . SGK1 is important for Th17 development (43, 44) , as well as for Th1 and Th2 development (45) . However, its role in Treg development is less clear. SGK1 levels (as measured by RNA) did not change significantly between conventionally activated T cells and iTregs, and overexpression of SGK1 had minimal effect on iTreg induction (Y. Singh and B. Cobb, unpublished observations). Therefore, SGK1 was not thought to be a relevant target of miR-15b/16 in the induction of iTregs.
In contrast, Rictor did appear to be a relevant target of miR15b/16. Its expression was reduced at both the protein and mRNA levels when miR-15b/16 was overexpressed (Fig. 6A, 6B ). The increase in protein level in Dicer 2/2 CD4 + T cells and the decrease in miR-15b/16-overexpressing cells was also observed at the mRNA level (Fig. 6B) . A luciferase reporter construct containing the 39UTR of Rictor was suppressed by overexpression of miR-15b/16, and suppression was significantly reduced when the predicted target sequence was mutated (Fig. 6C) . Furthermore, the miR-15b miRNA mimic reduced the level of Rictor expression in Dicer 2/2 CD4 + T cells (Fig. 6D) . The relevance of the increased Rictor expression impacting iTreg induction in Dicer 2/2 CD4 + T cells was tested by siRNA knockdown of Rictor, which enhanced the induction of iTregs in Dicer 2/2 CD4 + T cells by ∼1.5-fold (Fig. 6E) However, these experiments were performed at different times, and the basal level of Foxp3-expressing cells was higher with the cells used in these experiments. This and the problems inherent in comparing retroviral-transduced and siRNA-transfected experiments make it difficult to compare the effects of siRNA knockdown and miR-15b/16 expression on iTreg induction. Nevertheless, changes in Rictor levels over a broad range were important for iTreg induction, and most notably, the upregulation of Rictor in Dicer 2/2 CD4 + T cells appeared to play an important role in the reduced levels of iTreg induction.
To further address the relevance of miR-15b/16 regulation of Rictor on iTreg induction, we found that the siRNA knockdown of Rictor expression in T cells reversed the inhibition of iTreg induction when miR-15b/16 were inhibited by the miR-15 decoy (Fig. 6G) . However, quantifying the importance of miR-15b/16 regulation of Rictor expression, as opposed to other targets, will require the gene mutation of the target site in the Rictor 39UTR. Undoubtedly, other targets of miR-15b/16 will also play a role in iTreg induction; in fact, within the mTOR signaling pathway, miR-15b/16 additionally regulated the expression of mTOR. Interestingly, target prediction algorithms did not identify sites for miR-15b/16 in its 39UTR (29, 35) ; however, like Rictor, its expression was reduced by overexpression of miR15b/16 (Fig. 6A) , and an miRNA mimic for miR-15b decreased its expression in Dicer 2/2 CD4 + T cells (Fig. 6D) . Therefore, mTOR could have target sites for miR-15b/16 not recognized by the target prediction algorithms, or it may be regulated indirectly.
Changes in mTOR and Rictor levels were consistent with a decrease in AKT activation, as measured by phosphorylation of Ser 473 , but this was not reflected by any significant changes in FoxO1a or FoxO3a expression (Fig. 6A) . In contrast, mTORC1 activity was inhibited, as measured by phosphorylation of ribosomal protein S6. Therefore, miR-15b/16 appears to affect mTOR signaling downstream of mTORC1 but not by regulating the expression or phosphorylation of FoxO proteins. 
+ T cells. Further support for the importance of miR-29 came from the T cell-specific deletion of the locus encoding it, which results in a significant reduction in Tregs in vivo. However, little difference in the induction of iTregs was found under the conditions used, which included the addition of retinoic acid (34) . We found that the influence of miRNAs is greatest under suboptimal conditions for iTreg induction. Therefore, it would be interesting to determine whether the deletion of miR-29a affects the induction of iTregs in the conditions used in this study. No T cell-specific deletions of miR-15/16 or miR-24 have been characterized, to the best of our knowledge. However, such experiments would be complicated because both miR-15/16 and miR-24 are encoded on two separate loci, and it is not known whether one locus is preferentially expressed over the other in T cells or whether the deletion of one locus would impact the expression of the other. Furthermore, miR-15/16 is part of a family of related miRNAs that are capable of targeting the same sequences in messages. These include miR-195, miR-322, miR-424, miR-497, and miR-1907, so it could be difficult to ensure lack of expression of all of these miRNAs, which would make the interpretation of the effects on gene expression challenging. Therefore, the overexpression and blocking approach offers the advantage of characterizing the effects of this entire family. Because miR-15b/16 had the greatest effect in overexpression and blocking experiments, we focused on identifying relevant targets regulated by this miRNA family. Signaling through the mTOR pathway was enhanced in Dicer 2/2 CD4 + T cells, and expression of the mTORC2 components Rictor and mTOR was found to be regulated by miR-15b/16. It has been well established that a reduction in signaling through the mTOR pathway is required for Treg development. A T cell-specific deletion of mTOR results in the spontaneous induction of iTregs without the addition of TGF-b (18) . The expression of a constitutively active AKT inhibits iTreg induction (19) , and pharmacological inhibition of the mTOR signaling pathway enhances iTreg induction (20) . Therefore, regulation of this pathway by miRNAs is an obvious mechanism for fine-tuning its function in T cell development.
The regulation of mTORC2 by miR-15b/16 affected mTOR signaling by reducing AKT activity and subsequent downstream events. This disruption in mTOR signaling is consistent with the T cell-specific deletion of Rictor, which diminishes AKT activation and enhances iTreg induction (46) . It is also consistent with the effects observed in the T cell-specific deletion of mTOR (18) . However, in contrast to the T cell-specific deletion of mTOR, iTreg induction in miR-15b/16-overexpressing cells still required the addition of TGF-b. Also, the proximal events of TGF-b signaling were not affected in Dicer 2/2 CD4 + T cells as they were in Mtor 2/2 CD4 + T cells. Therefore, the effects on signaling by the reduction in mTOR levels do not entirely follow the complete loss of mTOR expression, suggesting that other signaling mechanisms involving the mTOR pathway exist that are only sensitive to large changes in mTORC activity. Interestingly, the reduced AKT activity in T cells overexpressing miR-15b/16 had no effect on FoxO protein levels or phosphorylation, suggesting that the change in AKT activation was not sufficient to regulate this part of the pathway. In contrast, it was sufficient to regulate mTORC1 activity, leading us to speculate that the decrease in both mTORC1 and mTORC2 levels from reduced mTOR expression amplified the effect of the reduced AKT activity. Alternatively, regulation of mTORC1 in T cells might be more sensitive to small changes in AKT activity.
The regulation of the mTOR signaling pathway is a major mechanism controlling Treg development, and miR-15b/16 affects this pathway by regulating the expression of Rictor and mTOR. However, there will undoubtedly be other important targets for this miRNA, as well as targets for miR-24 and miR-29a. Furthermore, the regulation of expression of these miRNAs will need to be differentially controlled in iTreg induction to enhance their levels over what is found in other Th subtypes. T cell activation results in a global change in miRNA levels through their turnover due to the destabilization of Argonaute proteins; however, transcriptional regulation of miRNA transcripts and their posttranscriptional processing are also important (47) . Therefore, it will be interesting to dissect the mechanisms controlling the expression of these important miRNAs.
